Ping An Biomedical Co., Ltd. (PASW) income statement
PASWNasdaqApparel & Other Finishd Prods of Fabrics & Similar Matl
$0.13+0.01 (+8.07%)
Close on Oct 19, 2026
Ping An Biomedical Co., Ltd. financial ratios
See a number that looks wrong?
Close on Oct 19, 2026
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin | 2.8% | 6.2% | 5.1% | – |
| Operating margin | -43.1% | -0.00% | 0.74% | – |
| Pre-tax margin | -43.0% | -0.78% | 0.05% | – |
| Net profit margin | -37.6% | -1.5% | -1.2% | – |
| Effective tax rate | – | – | -2,484.3% | – |
| Returns on capital | ||||
| Return on equity | -67.4% | 19.7% | 157.8% | – |
| Return on assets | -20.5% | -2.3% | – | – |
| Return on tangible assets | -20.5% | -2.3% | – | – |
| Return on invested capital | -40.9% | -0.06% | – | – |
| Return on capital employed | -76.2% | 0.03% | – | – |
| Return on total capital | -50.6% | -0.07% | – | – |
| NOPAT | -11.61M | -1.61K | 612.48K | – |
| Cash flow quality | ||||
| OCF / Sales | -18.8% | 16.7% | -7.4% | – |
| OCF / Net income | 0.50 | -11.39 | 6.12 | – |
| Efficiency | ||||
| Asset turnover | 0.55 | 1.54 | – | – |
| Fixed asset turnover | – | 15,688.88 | – | – |
| Receivables turnover | 1.19 | 2.17 | – | – |
| Days sales outstanding | 306.6 | 168.5 | – | – |
| Payables turnover | 2.71 | 5.46 | – | – |
| Days payables outstanding | 134.5 | 66.8 | – | – |
| Inventory turnover | 116.65 | 645.78 | – | – |
| Days inventory outstanding | 3.1 | 0.6 | – | – |
| Operating cycle | 309.7 | 169.0 | – | – |
| Cash conversion cycle | 175.2 | 102.2 | – | – |
| Liquidity | ||||
| Current ratio | 2.76 | 0.84 | – | – |
| Quick ratio | 2.74 | 0.84 | – | – |
| Cash ratio | 0.05 | 0.00 | – | – |
| Working capital | 40.62M | -10.27M | – | – |
| Net current asset value | 40.52M | -10.73M | – | – |
| Leverage | ||||
| Total debt | 10.00M | 10.00M | – | – |
| Net debt | 8.83M | 9.87M | – | – |
| Debt / Equity | 0.22 | -1.39 | – | – |
| Debt ratio | 14.6% | 17.6% | – | – |
| Assets to equity | 1.51 | -7.91 | – | – |
| Total debt / Capitalization | 18.1% | 355.6% | – | – |
| Cash flow to debt | -64.3% | 146.3% | – | – |
| Interest coverage | ||||
| EBIT / Interest expense | -47.88 | -0.00 | 0.35 | – |
| Per share | ||||
| Revenue per share | 1.67 | 4.87 | 4.59 | – |
| EPS (basic) | -0.69 | -0.07 | -0.06 | – |
| EPS (diluted) | -0.69 | -0.07 | -0.06 | – |
| Book value per share | 2.21 | -0.40 | -0.33 | – |
| Tangible book value per share | 2.21 | -0.40 | -0.33 | – |
| Cash per share | 0.06 | 0.0073 | 0.03 | – |
| Operating cash flow per share | -0.31 | 0.81 | -0.34 | – |
| Valuation at period end | ||||
| Market cap | 892.80M | – | – | – |
| Enterprise value | 894.19M | – | – | – |
| P/S | 26.1x | – | – | – |
| P/B | 19.7x | – | – | – |
| P/TBV | 19.7x | – | – | – |
| P/Gross profit | 940x | – | – | – |
| P/OCF | -139x | – | – | – |
| EV/Sales | 26.2x | – | – | – |
| EV/Gross profit | 942x | – | – | – |
| EV/OCF | -139x | – | – | – |
| Earnings yield | -1.4% | – | – | – |
| Shareholder yield | ||||
| Payout ratio | – | -25.1% | -966.2% | – |
| Cost structure | ||||
| SG&A to revenue | 18.5% | 6.0% | 4.4% | – |
| Per employee | ||||
| Total employees | 7 | 7 | 7 | 7 |
| Revenue per employee | 4.88M | 12.52M | 11.79M | – |
| Gross profit per employee | 135.64K | 773.84K | 605.74K | – |
| Operating profit per employee | -2.10M | -291 | 87.50K | – |
| Net income per employee | -1.83M | -183.45K | -141.99K | – |
| Growth | ||||
| Revenue 1Y growth | -61.0% | 6.1% | – | – |
| Gross profit 1Y growth | -82.5% | 27.8% | – | – |
| EBIT 1Y growth | -720,913.8% | -100.3% | – | – |
| Net income 1Y growth | -899.0% | -29.2% | – | – |
| Diluted EPS 1Y growth | -885.7% | -16.7% | – | – |
| Operating cash flow 1Y growth | -143.9% | 340.5% | – | – |
| Total assets 1Y growth | 20.3% | – | – | – |
| Total equity 1Y growth | 729.4% | -22.7% | -227.4% | – |
| Total equity 3Y CAGR | 114.3% | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.